Treatment Options Post Exposure to COVID-19
Introductory content goes here…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris placerat ullamcorper sem eu sodales. Praesent suscipit mauris nec augue bibendum, ut consequat massa sodales. Proin et lacus enim. Vivamus vulputate luctus ultrices. Quisque consequat porttitor fringilla. Mauris vitae nulla porttitor, gravida diam et, egestas mauris. Mauris convallis metus at urna rutrum, eget hendrerit metus porttitor. Maecenas posuere lorem rhoncus nisi eleifend mollis.
Web Tip: This has the potential to change everything and give us freedom like that already enjoyed by those vaccinated who have a normal immune system.
New COVID Vaccine Boosts Cellular Response in CLL Patients
CLL patients often have suboptimal COVID-19 vaccine responses and worse outcomes. GEO-CM04S1, a new type of vaccine, results in stronger T cell immunity.
EU Approves Acalabrutinib-Based Combinations for CLL
The EU commission has approved acalabrutinib in combination with venetoclax, with or without obinutuzumab, for the frontline treatment of CLL.
BTK Inhibitor Pause Did Not Help COVID-19 Vaccine Response
A three-week pause of BTK inhibitors was studied to see if it improved antibody response to COVID-19 booster vaccinations in CLL patients, but it did not.
Understanding NCCN Guidelines for CLL / SLL as a Patient
NCCN guidelines are the gold standard where CLL experts recommend best practices. Learn what CLL patients should know about the latest update.
U.S. Government to Help Patients Access Paxlovid in 2025
The U.S. Government Patient Assistance Program will continue to help individuals access Paxlovid for the treatment of COVID-19.
Recurrent COVID-19 in Chronic Lymphocytic Leukemia
There’s a 21 percent chance of chronic lymphocytic leukemia (CLL) patients getting a second COVID-19 infection within a year of the first infection.
RECENT NEWS
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.